Compounds > fructose-1,6-diphosphate

fructose-1,6-diphosphate and Diabetes Mellitus, Adult-Onset

fructose-1,6-diphosphate has been researched along with Diabetes Mellitus, Adult-Onset in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bochi, GV; Cargnin, LP; de Carvalho, JA; Gomes, P; Moresco, RN; Torbitz, VD1
Fujiwara, T; Hagisawa, Y; Izumi, M; Ohsumi, J; Okuno, A; Takahashi, K; Yoshida, T1
Dai, DZ; Dai, Y; Liu, HR; Tang, XY; Ying, HJ; Zhang, Q1
Bie, JB; Li, ZM; Song, HR; Xu, BL1
Campos, G; Durante, P; Gómez, ME; Raleigh, X; Ryder, E1

Reviews

1 review(s) available for fructose-1,6-diphosphate and Diabetes Mellitus, Adult-Onset

ArticleYear
[Recent advance in the discovery of allosteric inhibitors binding to the AMP site of fructose-1,6-bisphosphatase].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2011, Volume: 46, Issue:11

    Topics: Adenosine Monophosphate; Allosteric Site; Animals; Binding Sites; Blood Glucose; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Fructose-Bisphosphatase; Fructosediphosphates; Fructosephosphates; Humans

2011

Other Studies

4 other study(ies) available for fructose-1,6-diphosphate and Diabetes Mellitus, Adult-Onset

ArticleYear
An alternative pathway through the Fenton reaction for the formation of advanced oxidation protein products, a new class of inflammatory mediators.
    Inflammation, 2014, Volume: 37, Issue:2

    Topics: Acetylcysteine; Advanced Oxidation Protein Products; Antioxidants; Case-Control Studies; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Fructosediphosphates; Humans; Hydrogen Peroxide; Inflammation Mediators; Iron; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species

2014
CS-917, a fructose 1,6-bisphosphatase inhibitor, improves postprandial hyperglycemia after meal loading in non-obese type 2 diabetic Goto-Kakizaki rats.
    European journal of pharmacology, 2008, Dec-28, Volume: 601, Issue:1-3

    Topics: Alanine; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme Inhibitors; Fructose-Bisphosphatase; Fructosediphosphates; Fructosephosphates; Gluconeogenesis; Hyperglycemia; Liver; Male; Organophosphonates; Organophosphorus Compounds; Rats; Rats, Wistar

2008
Strontium fructose 1,6-diphosphate alleviates early diabetic testopathy by suppressing abnormal testicular matrix metalloproteinase system in streptozocin-treated rats.
    The Journal of pharmacy and pharmacology, 2009, Volume: 61, Issue:2

    Topics: Acid Phosphatase; Animals; Diabetes Complications; Diabetes Mellitus, Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Fructosediphosphates; gamma-Glutamyltransferase; Gene Expression; Hyperglycemia; Hypogonadism; L-Lactate Dehydrogenase; Male; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Rats; Rats, Sprague-Dawley; RNA, Messenger; Streptozocin; Succinate Dehydrogenase; Testis; Testosterone; Tissue Inhibitor of Metalloproteinases

2009
Isozyme analysis of human polymorphonuclear leukocyte phosphofructokinase from insulin resistant individuals.
    Biochemical and biophysical research communications, 1996, Aug-23, Volume: 225, Issue:3

    Topics: Adenosine Triphosphate; Case-Control Studies; Citrates; Citric Acid; Diabetes Mellitus, Type 2; Enzyme Activation; Enzyme Inhibitors; Fructosediphosphates; Fructosephosphates; Humans; Insulin Resistance; Isoenzymes; Kinetics; Neutrophils; Obesity; Phosphofructokinase-1; Substrate Specificity

1996